Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Gains from Sales and Divestitures: 2019-2021

Historic Gains from Sales and Divestitures for IDEAYA Biosciences (IDYA) over the last 2 years, with Dec 2021 value amounting to $7,312.

  • IDEAYA Biosciences' Gains from Sales and Divestitures was N/A to $7,312 in Q4 2021 from the same period last year, while for Dec 2021 it was $7,312, marking a year-over-year change of. This contributed to the annual value of $7,312 for FY2021, which is N/A change from last year.
  • According to the latest figures from Q4 2021, IDEAYA Biosciences' Gains from Sales and Divestitures is $7,312, which was down 0.00% from $7,312 recorded in Q3 2021.
  • In the past 5 years, IDEAYA Biosciences' Gains from Sales and Divestitures registered a high of $7,312 during Q1 2021, and its lowest value of $4,099 during Q2 2019.
  • In the last 2 years, IDEAYA Biosciences' Gains from Sales and Divestitures had a median value of $7,312 in 2021 and averaged $6,115.